NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.
01-01-2020
-31-12-2024
Show more information
Organisation
PRONOXIS AB